Search
for
Sort by
Research 511–540 of 1000+
- Fibroblasts – the cellular choreographers of wound healing
- Sebaceous gland abnormalities in fatty acyl CoA reductase 2 (Far2) null mice result in primary cicatricial alopecia
- Effect of Decellularized Extracellular Matrix Bioscaffolds Derived from Fibroblasts on Skin Wound Healing and Remodeling
- Dietary Vitamin A Impacts Refractory Telogen
- Allergic Dermatitis in Pêga Breed Donkeys (Equus asinus) Caused by Culicoides Bites in the Amazon Biome, Pará, Brazil
- A Kaleidoscope of Keratin Gene Expression and the Mosaic of Its Regulatory Mechanisms
- Platelet-Rich Plasma in Dermatology: New Insights on the Cellular Mechanism of Skin Repair and Regeneration
- First Symposium of Ichthyosis Experts
- X-linked Recessive Ectodysplasin A Mutations Induced Hypohidrotic Ectodermal Dysplasia and Severe Atopic Dermatitis Successfully Treated with Dupilumab
- miR-29a-5p Inhibits Prenatal Hair Placode Formation Through Targeting EDAR by ceRNA Regulatory Network
- Alopecia and Thyroid Disease
- The Functional Organization of Cutaneous Low-Threshold Mechanosensory Neurons
- Advances in skin grafting and treatment of cutaneous wounds
- Cutaneous wound healing: recruiting developmental pathways for regeneration
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- TRPA1 Modulates Mechanotransduction in Cutaneous Sensory Neurons
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics
- Advances of Stem Cell Therapeutics in Cutaneous Wound Healing and Regeneration
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Nonablative cutaneous remodeling using radiofrequency devices
- Cutaneous adverse effects of targeted therapies
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Cutaneous complications of chemotherapeutic agents
- Polymeric Micelle Nanocarriers for the Cutaneous Delivery of Tacrolimus: A Targeted Approach for the Treatment of Psoriasis
- Wnt signaling induces epithelial differentiation during cutaneous wound healing
- The role of estrogen in cutaneous ageing and repair
- Quality of life in cutaneous lupus erythematosus